KI-gestützte

Absci Investigates Novel Treatments for Genetic Hair Loss and Endometriosis: Phase 1/2a Clinical Trial Update

by

Absci Corporation, a generative AI-powered drug discovery company, has seen its stock price climb significantly since the start of 2024, reflecting investor interest in its expanding clinical pipeline. As of recent market observations, the company’s valuation has experienced a notable upward trajectory, driven largely by its efforts to leverage artificial intelligence in the identification and … Read more

Dementia Early Detection: New Breakthroughs in Blood Tests, AI, and Gut Health

by

AI and Blood Tests Transform Early Dementia Detection Recent advances in artificial intelligence and blood-based biomarkers are reshaping how clinicians approach the early detection of dementia, offering hope for interventions years before symptoms become apparent. Researchers worldwide are leveraging machine learning algorithms to analyze subtle changes in blood proteins, metabolites, and gut microbiome markers that … Read more